• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

亚洲的乳腺癌：发病率、死亡率、早期检测、乳房X光检查项目以及基于风险的筛查举措

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.

作者信息

Lim Yu Xian, Lim Zi Lin, Ho Peh Joo, Li Jingmei

机构信息

Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore.

Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.

出版信息

Cancers (Basel). 2022 Aug 30;14(17):4218. doi: 10.3390/cancers14174218.

DOI:10.3390/cancers14174218
PMID:36077752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9454998/
Abstract

Close to half (45.4%) of the 2.3 million breast cancers (BC) diagnosed in 2020 were from Asia. While the burden of breast cancer has been examined at the level of broad geographic regions, literature on more in-depth coverage of the individual countries and subregions of the Asian continent is lacking. This narrative review examines the breast cancer burden in 47 Asian countries. Breast cancer screening guidelines and risk-based screening initiatives are discussed.

摘要

2020年确诊的230万例乳腺癌病例中，近一半（45.4%）来自亚洲。虽然已在广泛地理区域层面研究了乳腺癌负担，但缺乏关于亚洲大陆各个国家和次区域更深入覆盖情况的文献。本叙述性综述考察了47个亚洲国家的乳腺癌负担。并讨论了乳腺癌筛查指南和基于风险的筛查倡议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/d65bf557043e/cancers-14-04218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/930d8b02f0e3/cancers-14-04218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/bb638f886256/cancers-14-04218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/d65bf557043e/cancers-14-04218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/930d8b02f0e3/cancers-14-04218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/bb638f886256/cancers-14-04218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811a/9454998/d65bf557043e/cancers-14-04218-g003.jpg

相似文献

1
Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.亚洲的乳腺癌：发病率、死亡率、早期检测、乳房X光检查项目以及基于风险的筛查举措
Cancers (Basel). 2022 Aug 30;14(17):4218. doi: 10.3390/cancers14174218.
2
Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review.乳房X光检查用于乳腺癌筛查在西方国家和亚洲国家都具有成本效益吗？：一项系统评价的结果
Asian Pac J Cancer Prev. 2013;14(7):4141-9. doi: 10.7314/apjcp.2013.14.7.4141.
3
Mammography screening: A major issue in medicine.乳腺 X 光筛查：医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
4
Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus.评估金砖国家及其他国家乳腺癌筛查项目在死亡率、病例病死率和伤残调整寿命年方面的差异。
BMC Med. 2023 Sep 1;21(1):299. doi: 10.1186/s12916-023-03004-4.
5
Screening for cancer in low- and middle-income countries.在中低收入国家进行癌症筛查。
Ann Glob Health. 2014 Sep-Oct;80(5):412-7. doi: 10.1016/j.aogh.2014.09.014.
6
Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.基于人群的亚洲女性乳腺癌筛查患病率及检测随机试验的中间测量结果：新加坡乳腺癌筛查项目
Cancer. 1998 Apr 15;82(8):1521-8.
7
Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review.亚洲乳腺癌早期检测策略的经济评价：系统评价。
Value Health Reg Issues. 2020 May;21:252-263. doi: 10.1016/j.vhri.2020.01.003. Epub 2020 May 6.
8
Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.针对乳腺癌平均风险女性进行数字化乳腺钼靶筛查，针对高风险女性进行磁共振成像（MRI）筛查：一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(3):1-55. Epub 2010 Mar 1.
9
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.针对40至49岁患乳腺癌平均风险女性的乳腺钼靶筛查：一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.
10
Breast cancer incidence and mortality before and after implementation of the German mammography screening program.德国乳腺 X 光筛查项目实施前后的乳腺癌发病与死亡情况。
Int J Cancer. 2020 Aug 1;147(3):709-718. doi: 10.1002/ijc.32767. Epub 2019 Dec 4.

引用本文的文献

1
Research on the Emotional Stress of Pregnancy-Associated Breast Cancer Patients and Its Effects on Child developmenT: The RESPECT.妊娠相关乳腺癌患者的情绪应激及其对儿童发育的影响研究：RESPECT研究
J Breast Cancer. 2025 Aug;28(4):280-287. doi: 10.4048/jbc.2025.0050.
2
A psychometric analysis for the adaptation of the comprehensive breast cancer knowledge test for the male population: a methodological study.针对男性群体改编综合乳腺癌知识测试的心理测量学分析：一项方法学研究。
Front Public Health. 2025 Jul 23;13:1535564. doi: 10.3389/fpubh.2025.1535564. eCollection 2025.
3
Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions.

本文引用的文献

1
Perspectives on the Overdiagnosis of Breast Cancer Associated with Mammographic Screening.乳腺钼靶筛查相关乳腺癌过度诊断的观点
J Breast Imaging. 2019 Dec 5;1(4):278-282. doi: 10.1093/jbi/wbz059.
2
Female Healthcare Workers' Knowledge, Attitude towards Breast Cancer, and Perceived Barriers towards Mammogram Screening: A Multicenter Study in North Saudi Arabia.沙特阿拉伯北部一项多中心研究：女性医护工作者的乳腺癌知识、态度及对乳房 X 光筛查的认知障碍
Curr Oncol. 2022 Jun 15;29(6):4300-4314. doi: 10.3390/curroncol29060344.
3
Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.
亚洲国家的乳腺癌筛查：流行病学、筛查实践、结果、挑战及未来方向
Korean J Radiol. 2025 Aug;26(8):743-758. doi: 10.3348/kjr.2025.0338.
4
Missense variants in PRKCD: elucidating their potential association with breast cancer.蛋白激酶Cδ（PRKCD）中的错义变体：阐明它们与乳腺癌的潜在关联。
Breast Cancer Res. 2025 Jul 28;27(1):139. doi: 10.1186/s13058-025-02090-x.
5
Impact of chemotherapy on sexual dysfunction in Turkish women with breast cancer: A single-center prospective cohort study.化疗对土耳其乳腺癌女性性功能障碍的影响：一项单中心前瞻性队列研究。
Medicine (Baltimore). 2025 Jul 18;104(29):e43516. doi: 10.1097/MD.0000000000043516.
6
Part I: consensus statements and expert recommendations for -negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.第一部分：亚太地区早期阴性乳腺癌的共识声明与专家建议：诊断与风险评估
Front Oncol. 2025 Jun 23;15:1507836. doi: 10.3389/fonc.2025.1507836. eCollection 2025.
7
Association of PRKCQ variants with breast cancer susceptibility and clinicopathological features.PRKCQ基因变异与乳腺癌易感性及临床病理特征的关联。
BMC Cancer. 2025 Jul 1;25(1):1069. doi: 10.1186/s12885-025-14471-8.
8
Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO health equity assessment toolkit data.印度尼西亚的乳腺癌发病率：一项使用世界卫生组织健康公平评估工具包数据的性别分类分析。
BMC Cancer. 2025 Jun 2;25(1):986. doi: 10.1186/s12885-025-14332-4.
9
Risk-adjusted breast screening: an Australian perspective and considerations for the Western Pacific.风险调整后的乳腺筛查：澳大利亚视角及西太平洋地区的考量
Lancet Reg Health West Pac. 2025 Mar 19;57:101520. doi: 10.1016/j.lanwpc.2025.101520. eCollection 2025 Apr.
10
Mutational spectrum and profile of breast and ovarian cancer patients in Saudi Arabia's western region: single center experience.沙特阿拉伯西部地区乳腺癌和卵巢癌患者的突变谱及特征：单中心经验
Discov Oncol. 2025 May 20;16(1):829. doi: 10.1007/s12672-025-02640-x.
家族史、遗传和非遗传乳腺癌风险预测模型预测的高危人群重叠：对风险分层的影响。
BMC Med. 2022 Apr 26;20(1):150. doi: 10.1186/s12916-022-02334-z.
4
Priorities for cancer research in low- and middle-income countries: a global perspective.中低收入国家癌症研究重点：全球视角。
Nat Med. 2022 Apr;28(4):649-657. doi: 10.1038/s41591-022-01738-x. Epub 2022 Apr 19.
5
Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening.防癌和筛查专家工作组关于乳腺癌筛查建议的最新动态。
Hong Kong Med J. 2022 Apr;28(2):161-168. doi: 10.12809/hkmj219622. Epub 2022 Apr 11.
6
BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.基于个体风险的乳腺癌筛查项目的个体化筛查方案（BREATHE）研究方案。
PLoS One. 2022 Mar 31;17(3):e0265965. doi: 10.1371/journal.pone.0265965. eCollection 2022.
7
Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.评估因乳腺 X 光筛查而导致的预期寿命损失的领先时间偏倚。
Breast Cancer Res. 2022 Feb 23;24(1):15. doi: 10.1186/s13058-022-01505-3.
8
Overview of Cancer Control in Armenia and Policy Implications.亚美尼亚癌症控制概述及政策影响
Front Oncol. 2022 Jan 11;11:782581. doi: 10.3389/fonc.2021.782581. eCollection 2021.
9
Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.假阳性筛查结果的累积风险：一项回顾性队列研究，使用来自挪威乳腺癌筛查项目10轮两年一次筛查的经验数据。
Cancer. 2022 Apr 1;128(7):1373-1380. doi: 10.1002/cncr.34078. Epub 2021 Dec 21.
10
Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review.COVID-19 大流行期间，乳腺癌筛查的障碍更加严重：综述。
Clin Imaging. 2022 Feb;82:224-227. doi: 10.1016/j.clinimag.2021.11.025. Epub 2021 Dec 7.